目的 研究血小板/淋巴细胞比值(platelet to lymphocyte ratio,PLR)对评估老年男性急性心肌梗死(acute myocardial infarction,AMI)患者住院期间新发房颤(new onset atrial fibrillation,NOAF)的临床价值。方法 以2014-01至2018-12于某院心血管内科就诊的241例老年男性AMI患者为研究对象。根据入院时是否发生NOAF,分成房颤组(n=40)和非房颤组(n=201)。搜集两组患者病历资料,并通过Logisitic回归及受试者工作特征(ROC)曲线分析PLR对老年男性AMI患者NOAF发生的预测价值。结果 (1)经Logisitic回归分析显示:血清三酰甘油(TG)、左心室射血分数(LVEF)、PLR均是老年男性AMI患者入院后NOAF发生的独立危险因素(P<0.05)。(2)ROC曲线分析显示:PLR预测老年男性急性AMI入院后NOAF的最佳截点为248.11,预测的敏感性为87.90%,特异性为95.9%,AUC曲线下面积为0.969(95%CI:0.939~0.9998;P<0.01)。结论 PLR评估老年男性AMI患者NOAF的发生具有一定的临床应用价值。
Abstract
ObjectiveTo study the applicability of the platelet to lymphocyte ratio (PLR) in evaluating the new onset atrial fibrillation among elderly male patients with acute myocardial infarction (AMI)during hospitalization.Methods A total of 241 elderly male patients with AMI who were treated in the Department of Cardiology of a hospital between January 2014 and December 2018 were included in this study. These patients were divided into the atrial fibrillation group and the non-atrial fibrillation group based on the occurrence of NOAF during admission. The medical records of the two groups of patients were collected. Logistic regression analysis and the receiver operating characteristic (ROC)curve were used to analyze the potential of PLR to predict the occurrence of NOAF in elderly male AMI patients.Results (1) Logistic regression analysis showed that serum triglyceride (TG), left ventricular ejection fraction (LVEF), and PLR were independent risk factors for NOAF in elderly male AMI patients after admission(P<0.05). (2)ROC curve analysis showed that the best cutoff point for PLR to predict NOAF in elderly male patients of AMI after admission was 248.11. The sensitivity of prediction was 87.90%, the specificity was 95.9%, and the area under the AUC curve was 0.969(95%CI: 0.939~0.9998;P<0.001).Conclusions PLR is significantly related to the occurrence of NOAF in elderly male AMI patients.
关键词
血小板/淋巴细胞比值 /
心房颤动 /
急性心肌梗死
Key words
platelet/lymphocyte ratio /
atrial fibrillation /
acute myocardial infarction
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Bahouth F, Mutlak D, Furman M, et al. Relationship of functional mitral regurgitation to new-onset atrial fibrillation in acute myocardial infarction[J]. Heart,2010,96(9):683-688.
[2] Bloch Thomsen P E, Jons C, Raatikainen M J, et al. Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the cardiac arrhythmias and risk stratification after acute myocardial infarction (CARISMA) study[J]. Circulation, 2012,122(13):1258-1264.
[3] Kundu A, O’Day K, Shaikh A Y, et al. Relation of atrial fibrillation in acute myocardial infarction to in hospital complications and early hospital readmission[J]. Am J Cardiol, 2016 ,117(8): 1213-1218.
[4] Delgado V,DiBiase L, Leung M,et al. Structure and function of the left atrium and left atrial appendage[J]. J Am CollCardiol,2017, 70(25):3157-3172.
[5] Li W, Liu Q, Tang Y. Platelet to lymphocyte ratio in the prediction of adverse outcomes after acute coronary syndrome:a meta-analysis[J]. Sci Rep,2017,7:40426.
[6] Zhou D, Fan Y, Wan Z, et al. Platelet-to-lymphocyte ratio improves the predictive power of GRACE risk score for long-term cardiovascular events in patients with acute coronary syndrome[J]. Cardiology, 2016,134(1):39-46.
[7] Prajapati J H, Sahoo S, Nikam T ,et al. Association of high density lipoprotein with platelet to lymphocyte and neutrophil to lymphocyte ratios in coronary artery disease patients[J]. J Lipids, 2014:686791.
[8] Zhang P, Shao L, Ma J. Toll-like receptors 2 and 4 predict new-onset atrial fibrillation in acute myocardial infarction patients[J]. Int Heart J,2018,59(1):64-70.
[9] Camici G G, Savarese G, Akhmedov A, et al. Molecular mechanism of endothelial and vascular aging: implications for cardiovascular disease[J].Eur Heart J,2015, 36(48):3392-403.
[10] Gungor H, Babu A S, Zencir C,et al. Association of preoperative platelet-to-lymphocyte ratio with atrial fibrillation after coronary artery bypass graft surgery[J]. Med Princ Pract, 2017,26(2):164-168.
[11] Ghaffari S, Nadiri M, Pourafkari L,et al. The predictive value of total neutrophil count and neutrophil/lymphocyte ratio in predicting in hospital mortality and complications after STEMI[J]. J Cardiovasc Thorac Res, 2014,6(1):35-41.
[12] He J, Li J, Wang Y, et al. Neutrophil-to-lymphocyte ratio (NLR)predicts mortality and adverse-outcomes after ST-segment elevation myocardial infarction in Chinese people[J]. Int J Clin Exp Pathol, 2014, 7(7):4045-4056.
[13] Goliasch G, Forster S, El-Hamid F, et al. Platelet count predicts cardiovascular mortality in very elderly patients with myocardial infarction[J].Eur J Clin Invest,2013, 43(4):332-340.
[14] Demirtas S, Karahan O, Yazici S,et al.The relationship between complete blood count parameters and Fontaine’s Stages in patients with peripheral arterial disease[J].Vascular,2014,22(6):427-431.
[15] Jennings L K.Mechanisms of platelet a ctivation: need for new strategies to protect against platelet-mediated atherothrombosis [J].Thromb Haemost,2009, 102(2):248-257.
[16] Freynhofer M K, Bruno V, Wojta J, et al. The role of platelets in athero-thrombotic events[J]. Curr Pharm Des,2012,18(33):5197-5214.
[17] Bayturan O, Puri R, Tuzcu E M,et al. Atrial fibrillation, progression of coronary atherosclerosis and myocardial infarction[J]. Eur J Prev Cardiol,2017 ,24(4):373-381.
[18] Temiz A, Gazi E, Güngör Ö,et al. Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction[J]. Med Sci Monit,2014, 20:660-665.
[19] Zuo K,Yang X. Decreased platelet-to-lymphocyte ratio as predictor of thrombogenesis in nonvalvular atrial fibrillation[J]. Herz,2018,12.
[20] Zhou D, Fan Y, Wan Z, et al. Platelet-to-lymphocyte ratio improves the predictive power of GRACE risk score for long-term cardiovascular events in patients with acute coronary syndrome[J]. Cardiology, 2016,134(1):39-46.
[21] Toprak C, Tabakci M M, Simsek Z,et al. Platelet/lymphocyte ratio was associated with impaired myocardial perfusion and both in-hospital and long-term adverse outcome in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention[J]. Postepy Kardiol Interwencyjnej,2015,11(4): 288-297.